City
Epaper

No definitive agreement on commercial supplies with Moderna: Cipla

By IANS | Updated: June 29, 2021 21:55 IST

New Delhi, June 29 There is no definitive agreement yet between Cipla and US major Moderna on commercial ...

Open in App

New Delhi, June 29 There is no definitive agreement yet between Cipla and US major Moderna on commercial supplies of Covid 19 vaccines, Cipla said on Tuesday.

Cipla said it is helping Moderna with approvals and imports of vaccines to be donated to India.

"Cipla Limited is supporting Moderna, Inc. with the regulatory approval and importation of vaccines to be donated to India. At this stage, there is no definitive agreement on commercial supplies", Cipla said in a statement to .

Moderna Inc, a biotechnology company pioneering messenger RNA

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: usNew DelhiCipla limitedThe new delhi municipal councilDelhi south-westCiplaCipla ltd.
Open in App

Related Stories

Social ViralSanta Spotted in US Skies? Netizens Report Red Sleigh Seen Over Multiple Cities (Watch Videos)

InternationalNorth Carolina Plane Crash: Retired NASCAR Driver Greg Biffle and Family Among Seven Killed in Statesville Jet Crash

International'Warrior Dividend': Donald Trump Announces $1,776 Christmas Bonus to Active US Soldiers

National‘Harassing Crores for a Few’: Ex-CEC S.Y. Quraishi Criticises SIR Process at Lokmat National Conclave 2025

NationalLokmat National Conclave 2025: Manoj Jha Flags ‘Freebies Culture’, Says Elections Are No Longer Fair

Health Realted Stories

HealthGujarat's Foster Parent Scheme provides lifeline to orphaned children in Banaskantha

HealthFSSAI cracks down on ‘herbal tea’, says only Camellia sinensis qualifies

HealthPunjab CM approves cashless treatment of Rs 10 lakh to every family

HealthGST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026

HealthSun Pharma’s Taro recalls over 17,000 units of antifungal shampoo in US: FDA